You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
AZZ Inc. raised FY2027 guidance to $1.825–$1.875B sales, $380–$420M Adjusted EBITDA and $7.00–$7.30 Adjusted Diluted EPS; it expects Washington, MO to be accretive in FY2027.
AZZ Inc. filed Amendment No. 1 to its Form 10-Q for the quarterly period ended August 31, 2026, solely to add omitted monthly share repurchase disclosure. It does not affect previously reported financial results.
AZZ reported record quarterly sales of $486.9 million, up 16.7%, and raised its fiscal 2027 outlook to sales of $1.825 billion to $1.875 billion, adjusted EBITDA of $380 million to $420 million, and adjusted diluted EPS of $7 to $7.30.
AZZ reported second-quarter sales of $486.9 million, up 16.7%. It raised fiscal year 2027 guidance to sales of $1.825 - $1.875 billion, Adjusted EBITDA of $380 - $420 million, and Adjusted Diluted EPS of $7.00 - $7.30.
AZZ reported six-month sales of $935.4 million and operating income of $160.8 million; net income was $110.5 million versus $260.3 million, primarily due to a larger prior-period AVAIL JV gain. Operations generated $140.0 million of cash, and total liquidity was $376.4 million.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
TL;DR. AZZ delivered record Q2 FY2027 sales of $486.9 million, up 16.7% year-over-year, with adjusted diluted EPS of $2.00 (+29%), 80 bps gross margin expansion, and operating cash flow of $102.8 million, and raised full-year FY2027 guidance for sales, adjusted EBITDA, and adjusted EPS.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted earnings per share (non-GAAP) non-GAAP | $2 | Three Months Ended August 31, 2026 filing | — |
|
|
|||
| Adjusted EBITDA (non-GAAP) non-GAAP | 210.33M | Six Months Ended August 31, 2026 | — |
|
|
|||
| Adjusted EBITDA margin non-GAAP | 22.8% | Q2 FY2027 | — |
| Adjusted EBITDA per Credit Agreement non-GAAP | 403.09M | Trailing Twelve Months Ended August 31, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net income $167.46M
+$93.54M Depreciation and amortization
+$45.49M Interest expense
+$58.5M Income tax expense
+$8.2M Cash items
+$14.06M Non-cash items
+$15.84M Equity in earnings, net of distributions
= Adjusted EBITDA per Credit Agreement $403.09M
|
|||
| Adjusted net income and adjusted earnings per share (non-GAAP) non-GAAP | 115.9M | Six Months Ended August 31, 2026 | — |
|
|
|||
| Metal Coatings Adjusted EBITDA non-GAAP | $71.6M | Q2 FY2027 | — |
|
|
|||
| Metal Coatings Adjusted EBITDA margin non-GAAP | 30.7% | Q2 FY2027 | — |
| Precoat Metals Adjusted EBITDA non-GAAP | $53.8M | Q2 FY2027 | — |
|
|
|||
| Precoat Metals Adjusted EBITDA margin non-GAAP | 21.2% | Q2 FY2027 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AZZ
this stock
Azz Inc
|
$3.66B | +17.3% | +14.5% | 22.0 | 2.8% |
|
CTAS
Cintas Corp
|
$89.90B | +18.2% | +6.4% | 44.7 | 2.8% |
|
RELX
Relx PLC
|
$69.86B | -0.6% | — | — | 0.1% |
|
TRI
Thomson Reuters Corp
|
$48.79B | -14.6% | — | — | 3.0% |
|
CPRT
Copart Inc
|
$30.09B | -18.4% | +24.7% | 21.0 | 3.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AZZ | -6.5% | -8.1% | -10.1% | -6.5% | +17.3% |
| SPY | -2.7% | -5.6% | -0.5% | -2.7% | +7.8% |
| vs SPY | -3.8% | -2.6% | -9.6% | -3.8% | +9.5% |
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
